Zolmitriptan

Zolmitriptan
Klinički podaci
Prodajno imeZomig
Drugs.comMonografija
Kategorija trudnoće
  • AU: B3
  • US: C (Mogući rizik)
Način primeneOralno, nazalni sprej
Pravni status
Pravni status
Identifikatori
CAS broj139264-17-8 Зелена квачицаДа
ATC kodN02CC03 (WHO)
PubChemCID 60857
IUPHAR/BPS60
DrugBankDB00315 Зелена квачицаДа
ChemSpider54844 Зелена квачицаДа
UNII2FS66TH3YW Зелена квачицаДа
KEGGD00415 Зелена квачицаДа
ChEBICHEBI:10124 Зелена квачицаДа
ChEMBLCHEMBL1185 Зелена квачицаДа

Zolmitriptan (Zomig, Zomigon, AscoTop, Zomigoro) je selektivan agonist serotoninskog receptora, 1B i 1D podtipova. On je triptan koji se koristi za tretman napada akutne migrene.[1][2]

Reference

  1. ^ Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803. 
  2. ^ Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0. 

Literatura

Spoljašnje veze

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.